InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Despite strong Q3 earnings, shares of AUPH stock are in steep decline today after it lowered its full-year sales guidance.
The post Why Is Aurinia Pharmaceuticals (AUPH) Stock Down 30%? appeared first on InvestorPlace.
More From InvestorPlace